News

Avicanna gets patent for cannabinoid skin cream

Published on August 22, 2025 by Pat Bulmer

Photo: Contributed

Want clearer skin? Try cannabis.

Avicanna has been granted a U.S. patent for a cannabinoid-based product that’s meant to make your skin clearer.

The patent is for a topical gel that combines cannabinoids with antioxidants, anti-microbial agents and anti-inflammatory agents to treat and prevent skin diseases and conditions, including acne, wrinkles, rosacea and erythema, the Toronto-based biopharmaceutical company said.

“We are delighted with the issuance of another USPTO patent as we continue to expand our intellectual property portfolio,” said CEO Aras Azadian in a news release. “We are excited about the potential of this patent.”

The company also had financial results to announce. The news wasn’t bad.

— “The company generated revenue of $6.16 million and $12.48 million for the three- and six-month periods ended June 30, 2025, representing a 1% increase and a 1% decrease, respectively, compared to the corresponding periods in 2024,” a financial statement said.

— “Gross profit for the second quarter was $3.13 million, with a six-month total of $6.73 million, translating to gross margins of 51% and 54%, respectively—up from 47% in the prior-year periods. This improvement was primarily driven by increased service and licensing revenue from international markets.”

— “For the second quarter, the company reported an adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) loss of $0.25 million and an adjusted EBITDA gain of $0.18 million for the six-month period. This marks a notable improvement from the same periods in 2024.”

Quarterly accomplishments included more products being listed and launching a research trial to evaluate the effectiveness of an oral cannabis extract on osteoarthritic pain, the report said.